June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
June 2026
The global AAV gene therapy market size was evaluated at USD 2.85 billion in 2025 and is predicted to hit around USD 27.41 billion by 2035, with a CAGR of 25.39%.
June 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
May 2026
The global gene-replacement therapy market analysis covers market size, growth drivers, key players, pipeline advances, and regulatory trends shaping future demand.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global automation, digitization and robotics in cell and gene therapy manufacturing market size was evaluated at USD 950.00 million in 2025 and is predicted to hit around USD 5,275.10 million by 2035, growing at a CAGR of 18.70%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
January 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
July 2025
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
July 2025
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 11.60 billion in 2024, with a CAGR of 26.62%.
July 2025
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
July 2025
Explore the cell and gene therapy patient access and reimbursement Market, driven by evolving payer policies, value-based care models, and rising adoption of high-cost cell and gene therapies.
July 2025
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
July 2025
The global nucleic acid therapeutics market size reached USD 5.77 billion in 2024 and is projected to surpass around USD 17.02 billion by 2034 with a solid CAGR of 11.42%.
June 2026
The global phage therapy market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.92 billion by 2035, growing at a CAGR of 4.06%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global regenerative medicine in dermatology market is poised to grow as advanced cell-based and biomaterial therapies revolutionize skin repair and restoration.
June 2026
The global gene identification market is expanding with rising adoption of genomics, precision medicine, and next-generation sequencing technologies.
June 2026
The US brachytherapy market size was evaluated at USD 345.22 million in 2025 and is predicted to hit around USD 699.86 million by 2035, growing at a CAGR of 7.32%.
June 2026
The global nerve repair and regeneration market size is expected to be worth around USD 19.76 billion by 2035 from USD 8.94 billion in 2025 with a CAGR of 8.25%.
June 2026
The global proton therapy market size surpassed USD 648.64 million in 2025 and is projected to surpass around USD 2,229.88 million by 2035 with a CAGR of 13.14%.
June 2026
The global estrogen replacement therapy market size was evaluated at USD 11.75 billion in 2025 and is predicted to hit around USD 20.49 billion by 2035, growing at a CAGR of 5.72%.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global next generation bioprinting market is expected to grow at a significant CAGR of 29.85% during the forecast period from 2026 to 2035.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com